Navigation Links
OncoGenex Pharmaceuticals Announces OGX-427 Treatment Demonstrates Safety, Evidence of Declines in Circulating Tumor Cells and Reductions in Tumor Markers in a Phase 1 Cancer Trial
Date:5/30/2009

BOTHELL, WA, and VANCOUVER, May 30 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today announced preliminary results of a Phase 1 trial presented during an oral presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting. Preliminary results as of April 2009 showed that OGX-427 was well tolerated as a monotherapy. In addition, OGX-427 demonstrated declines in circulating tumor cells at all doses evaluated as well as evidence of reduction in tumor markers. Reductions in circulating tumor cells and tumor markers both suggest single-agent activity warranting further clinical investigation.

The Phase 1 trial has evaluated 41 patients with a variety of cancers to date; enrollment is ongoing. The first phase of the study evaluated increasing doses of OGX-427 as a single agent up to 1000 mg. A maximum tolerated dose was not identified up to and including the 1000-mg dose of OGX-427 monotherapy. Subsequently, as defined by the protocol, an 800-mg dose of OGX-427 in combination with docetaxel was evaluated, to be followed by a 1000-mg dose of OGX-427 plus docetaxel. OGX-427 is administered as three loading doses within the first 9 days and then continued weekly, with three weeks defined as a treatment cycle, until disease progression or toxicity. In those groups receiving OGX-427 in combination with docetaxel, 75mg/M(2) docetaxel was administered on Day 1 of every 3-week cycle starting after completion of the OGX-427 loading doses.

Safety Results

Patients enrolled had a diagnosis of breast, ovarian, prostate or non-small cell lung cancer and most had failed multiple prior chemotherapy treatments. A median of 2 cycles (range of 1-8 cycles) was administered with the following safety results for OGX-427 as monotherapy:

    -   Criteria for a maximum tolerated dose were 
'/>"/>
SOURCE OncoGenex Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. OncoGenex Pharmaceuticals to Webcast ASCO Reception on May 30, 2009
2. OncoGenex Pharmaceuticals Announces Release of Two ASCO Abstracts: Impact of OGX-011 on Survival in Randomized Phase 2 Trial and Phase 1 Safety Data for OGX-427
3. OncoGenex Pharmaceuticals Clinical Programs to be Featured in Oral Presentations at the American Society of Clinical Oncology Annual Meeting
4. OncoGenex Reports First Quarter Financial Results
5. OncoGenex Pharmaceuticals to Release First Quarter Financial Results
6. OncoGenex Receives Confirmation from FDA on the Design of a Second Phase 3 Trial Evaluating OGX-011 for the Treatment of Advanced Prostate Cancer
7. OncoGenex Pharmaceuticals Named Life Sciences Company of the Year by LifeSciences British Columbia
8. OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009
9. OncoGenex Pharmaceuticals to Webcast Financial Results for Fourth Quarter and Fiscal Year 2008 and Provide Outlook for 2009
10. OncoGenex Provides Update on Two-Year Survival Data from Ongoing Phase 1/2 Clinical Trial of OGX-011 in Non-Small Cell Lung Cancer
11. OncoGenex To Present At The RBC Capital Markets 2008 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... the National Institute of Standards and Technology (NIST) ... a new design for an atomic clock that ... a microcomb. , The microcomb clock, featured on ... new journal Optica ,* is the first ... its accurate conversion of optical frequencies to lower ...
(Date:7/22/2014)... --  BioTE Medical , a leading provider of ... today announced the addition of Dr. Neal ... is joining the BioTE Medical Advisory Board as ... was residency trained in Family Medicine and Emergency ... emergency physician still practicing at a large metropolitan ...
(Date:7/22/2014)... 2014 Automated cell culture systems are ... cell culture. They allow production of optimum cells at ... in drug discovery and industries and biopharmaceutical companies. Cell ... iPSC research, cryobanking, cell-based assays, and cellular expression systems ... Analysts forecast the Global Cell Culture market ...
(Date:7/22/2014)... PA (PRWEB) July 22, 2014 Two ... Center’s Board of Directors at its annual Shareholders Meeting ... Chief Information Officer of The PFM Group, and Stephen ... Science Center also announced the election of Michael A. ... Board Vice Chair and Richard P. Jaffe, Esq., of ...
Breaking Biology Technology:'Comb on a chip' powers new NIST/Caltech atomic clock design 2Dr. Neal Rouzier Joins BioTE Medical 2Dr. Neal Rouzier Joins BioTE Medical 3Global Cell Culture Market to Grow at 10.27% CAGR by 2018 Forecasts a New Research Report ReportsnReports.com 2Global Cell Culture Market to Grow at 10.27% CAGR by 2018 Forecasts a New Research Report ReportsnReports.com 3Global Cell Culture Market to Grow at 10.27% CAGR by 2018 Forecasts a New Research Report ReportsnReports.com 4Two New Members Elected to University City Science Center Board of Directors 2Two New Members Elected to University City Science Center Board of Directors 3
... (NYSE: DGX ), the leading provider of diagnostic ... shareholders,on Friday, May 16th at 10:30 am ET., ... Relations,section of the company Web site at http://www.questdiagnostics.com/investor ... broadcast, a replay will be available on,the Web site ...
... study supports the potential for QLT,s drug elution technology ... reduce and ... QLT Inc. (NASDAQ: QLTI; TSX:,QLT) announced today results from ... QLT Plug Delivery, Inc., of its punctal plug,drug delivery ...
... 12 Amylin Pharmaceuticals,Inc. (Nasdaq: AMLN ) will ... May 14, 2008 at 3:05 p.m. CT / 1:05 ... Finance and Chief Financial Officer of,Amylin Pharmaceuticals, will be ... breakout session will be webcast, and a,recording will be ...
Cached Biology Technology:QLT reports initial proof of concept data for punctal plug delivery technology 2QLT reports initial proof of concept data for punctal plug delivery technology 3QLT reports initial proof of concept data for punctal plug delivery technology 4
(Date:7/22/2014)... feature natural habitats and trees and not just asphalt ... to a University of Colorado Boulder study. , Working ... provide stress-reducing benefits for youth, according to a paper ... The study is one of the first of its ... to green settings and stress. , "Many schools already ...
(Date:7/22/2014)... Conn. , July 22, 2014 ... the growing m-commerce market, announces its next generation smart ... 30-minute consumer oriented television show that airs on ... NewsWatch regularly features top technology ... July 31st on the History Channel (6:00-6:30am ET/PT) ...
(Date:7/21/2014)... researchers have detected genetic fragments of Middle East Respiratory ... holding a camel infected with the virus. The work, ... open-access journal of the American Society for Microbiology, indicates ... disease can be transmitted through the air. , MERS, ... has been identified in 699 people as of June ...
Breaking Biology News(10 mins):Natural-terrain schoolyards reduce children's stress, says Colorado University-Boulder study 2Natural-terrain schoolyards reduce children's stress, says Colorado University-Boulder study 3NXT-ID's Next Generation Wocket Smart Wallet to be Featured on NewsWatch, Airing on History Channel, FYI Network and ION Network 2NXT-ID's Next Generation Wocket Smart Wallet to be Featured on NewsWatch, Airing on History Channel, FYI Network and ION Network 3Middle East Respiratory Syndrome coronavirus detected in the air of a Saudi Arabian camel barn 2
... between tiny single-celled algae and highly specialized bacteria. Their ... the oceans by taking nitrogen from the atmosphere and ... use. Details of the symbiosis, published in ... from the investigation of a mysterious nitrogen-fixing microbe with ...
... Just as women are advised to get plenty of folic ... new research suggests another very similar nutrient may one day ... Consuming greater amounts of choline ... may lower an infant,s vulnerability to stress-related illnesses, such as ...
... Bethesda, MD FASEB MARC (Minority Access to Research ... the 2012 Biomedical Engineering Society (BMES) Annual Meeting in ... meant to promote the entry of underrepresented minority students, ... science community and to encourage the participation of young ...
Cached Biology News:Unusual symbiosis discovered in marine microorganisms 2Unusual symbiosis discovered in marine microorganisms 3Unusual symbiosis discovered in marine microorganisms 4Nutrient in eggs and meat may influence gene expression from infancy to adulthood 2Nutrient in eggs and meat may influence gene expression from infancy to adulthood 3
... Many differences exist between the various commercial ... glass slide used, the length and GC ... and the manufacturing protocol employed all influence ... analysis. With all the different variables ...
... The ICS-1500 system provides excellent ... dual-piston pumping, electrolytic suppression, and column ... instrument offers outstanding sensitivity and stability. ... quieter baselines for trace-level work. Operate ...
... Automatic grid, subgrid and spot finding overcome tedious ... template assignment , ... Extensive background and signal options to optimize, ... results , Characterize more precisely through ...
... UNIchip AV-400 contains 400 unique ... nitrocellulose-coated glass slide. The proteins, a ... are arrayed in quadruplicate for high-quality ... specific chip layout guarantee high validity ...
Biology Products: